Sylvia T Hoffstein

Title: Sylvia T. Hoffstein: Innovator in Leukotriene Antagonists

Introduction

Sylvia T. Hoffstein is a notable inventor based in Haverford, PA (US). She has made significant contributions to the field of pharmacology, particularly in the development of leukotriene antagonists. Her work has implications for treating diseases where LTB4 is a contributing factor.

Latest Patents

Hoffstein holds a patent for a method of inhibiting the effects of LTB4 through the administration of specific compounds. This patent outlines a structural formula that includes various components, such as phenyl groups and alkyl chains, which are essential for the effectiveness of the treatment. The patent is particularly relevant for conditions where LTB4 plays a critical role.

Career Highlights

Throughout her career, Sylvia T. Hoffstein has been associated with SmithKline Beckman Corporation, where she has contributed to innovative research and development. Her expertise in pharmacology and chemistry has led to advancements in therapeutic methods.

Collaborations

Hoffstein has worked alongside esteemed colleagues such as Seymour Mong and John G. Gleason. Their collaborative efforts have furthered research in the field and enhanced the understanding of leukotriene antagonists.

Conclusion

Sylvia T. Hoffstein's contributions to the field of pharmacology, particularly through her patent on leukotriene antagonists, highlight her role as an influential inventor. Her work continues to impact the treatment of diseases associated with LTB4.